Kyongbo Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio

Latest as of June 2026: 0.00x

Kyongbo Pharmaceutical Co Ltd cash flow-to-debt ratio. Kyongbo Pharmaceutical Co Ltd (214390) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of ₩-565.17 Million could theoretically repay 0% of its total liabilities (₩220.58 Billion) in one year. Check earnings quality score of Kyongbo Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

CF-to-Debt Ratio

0.00x
Operating CF / Total Liabilities

Operating Cash Flow

₩-565.17 Million
KRW

Total Liabilities

₩220.58 Billion
KRW

Data as of

Jun 2026
Most recent filing

Cash Flow-to-Debt Ratio of Kyongbo Pharmaceutical Co Ltd (2014–2025)

Cash flow-to-debt ratio of Kyongbo Pharmaceutical Co Ltd from 2014 to 2025. Historical debt coverage capacity for Kyongbo Pharmaceutical Co Ltd across 12 annual periods. Check Kyongbo Pharmaceutical Co Ltd (214390) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Kyongbo Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2014–2025)

Kyongbo Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Kyongbo Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Kyongbo Pharmaceutical Co Ltd cash flow conversion.

Year CF-to-Debt Ratio Operating CF (KRW) Total Liabilities YoY Change
2025 0.04x ₩7.46 Billion ₩173.80 Billion ▲ +3862.2%
2024 0.00x ₩149.12 Million ₩137.73 Billion ▼ -97.3%
2023 0.04x ₩4.84 Billion ₩121.92 Billion ▼ -62.0%
2022 0.10x ₩10.13 Billion ₩96.84 Billion ▼ -46.9%
2021 0.20x ₩17.97 Billion ₩91.28 Billion ▼ -8.0%
2020 0.21x ₩20.80 Billion ₩97.18 Billion ▼ -19.8%
2019 0.27x ₩23.67 Billion ₩88.65 Billion ▲ +1803.2%
2018 -0.02x ₩-1.14 Billion ₩72.61 Billion ▼ -103.8%
2017 0.41x ₩25.81 Billion ₩63.36 Billion ▲ +19.5%
2016 0.34x ₩25.33 Billion ₩74.33 Billion ▲ +484.0%
2015 0.06x ₩4.24 Billion ₩72.67 Billion ▼ -63.7%
2014 0.16x ₩16.04 Billion ₩99.70 Billion —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.